Patient-Reported Outcomes Indicate Unfavorable Benefit–Risk Profiles of Antidepressants in Older Adults
Introduction: Treatment with antidepressants from different drug classes is often limited by reduced efficacy and frequent adverse drug reactions, particularly in older adults. Traditional clinical assessments evaluate improvement and side effects separately and do not capture how patients weigh benefits against adverse effects. Patient-reported symptom measures allow the calculation of an individualized benefit-risk ratio, providing a more comprehensive assessment of treatment effectiveness and tolerability. Methods: This cross-sectional, multicenter questionnaire study was conducted at two German and one Croatian psychiatric/geriatric centers. Adult patients receiving antidepressants (or antipsychotics for depressive disorders) for at least 6 weeks completed a standardized interview assessing perceived treatment benefits for 4 core depressive symptoms and 17 adverse drug reaction symptoms on visual analog scales. Reported adverse drug reactions were evaluated by healthcare professionals using the World Health Organization-Uppsala Monitoring Centre causality assessment system. Patient-reported adverse drug reaction burdens, treatment benefits, and individual benefit-risk quotients were calculated. Associations between demographic and clinical variables and patient-perceived benefit-risk balance were analyzed using multinomial logistic regression. Results: Geriatric inpatients showed limited awareness of their antidepressant indication (57% unaware) and lower rates of depression diagnoses (39%) than psychiatric patients (100%). Psychiatric patients reported greater improvement in depressive symptoms, whereas adverse drug reactions were common across all groups. Increasing age significantly reduced the likelihood of a positive patient-reported benefit-risk ratio (-4% per year), independent of gender and care setting. Discussion: Patient-reported outcome measures are commonly used to assess quality of life. Here, they were applied specifically to evaluate perceived antidepressant benefits and risks. The findings demonstrate an age-related decline in patient-perceived antidepressant benefit-risk balance and emphasize the importance of systematically integrating patient-reported measures into clinical practice.
Authors
- Thea Laurentius (ORCID: https://orcid.org/0000-0003-1335-2550)
- Paula Marinović (ORCID: https://orcid.org/0000-0002-5306-1291)
- Nada Božina (ORCID: https://orcid.org/0000-0001-6016-1699)
- Maja Živković (ORCID: https://orcid.org/0000-0002-0447-6626)
- Michael Paulzen (ORCID: https://orcid.org/0000-0003-4198-5160)
- Katja Susanne Just (ORCID: https://orcid.org/0000-0002-6782-8078)
- Julia Stingl (ORCID: https://orcid.org/0000-0002-1566-8156)
- Justyna Wozniak (ORCID: https://orcid.org/0000-0002-2769-479X)
- Jason Radermacher
- Cornelius Bollheimer (ORCID: https://orcid.org/0000-0003-3927-1716)
Institutions
- Carl von Ossietzky Universität Oldenburg (DE)
- University Hospital Centre Zagreb (HR)
- University of Zagreb (HR)
- Heidelberg University (DE)
- Alexian Brothers Health System (US)
- Universitätsklinikum Aachen (DE)
- Klinik und Poliklinik für Psychiatrie und Psychotherapie des Kindes- und Jugendalters (DE)
Publication Details
- Journal
- Pharmacopsychiatry
- Published
- 2026-11-17
- DOI
- https://doi.org/10.1055/a-2989-3368
- Primary Topic
- Treatment of Major Depression
- Type
- article
- Field-Weighted Citation Impact
- 0.00